Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Meriney

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Physiology|July 13, 2014
Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonistTyler B Tarr, David Lacomis, Stephen W Reddel, et al.
Frontiers in Cellular Neuroscience|July 21, 2025
Chronic benzodiazepine treatment triggers gephyrin scaffold destabilization and GABA<sub>A</sub>R subsynaptic reorganizationCaitlyn A Chapman, Nadya Povysheva, Tyler B Tarr, et al.
Human Molecular Genetics|February 9, 2023
Potentiation of neuromuscular transmission by a small molecule calcium channel gating modifier improves motor function in a severe spinal muscular atrophy mouse modelKristine S Ojala, Cassandra J Kaufhold, Mykenzie R Davey, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 21, 2013
Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndromeTyler B Tarr, Waqas Malick, Mary Liang, et al.
Annals of the New York Academy of Sciences|November 11, 2017
Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leadsStephen D Meriney, Tyler B Tarr, Kristine S Ojala, et al.
Journal of Neurophysiology|April 19, 2023
Simulations of active zone structure and function at mammalian NMJs predict that loss of calcium channels alone is not sufficient to replicate LEMS effectsScott P Ginebaugh, Yomna Badawi, Rozita Laghaei, et al.
Journal of Cell Science|March 11, 2010
Sustained synaptic-vesicle recycling by bulk endocytosis contributes to the maintenance of high-rate neurotransmitter release stimulated by glycerotoxinFrederic A Meunier, Tam H Nguyen, Cesare Colasante, et al.
Journal of Neurophysiology|January 24, 2018
Transmitter release site organization can predict synaptic function at the neuromuscular junctionRozita Laghaei, Jun Ma, Tyler B Tarr, et al.
American Journal of Human Genetics|June 12, 2010
GJC2 missense mutations cause human lymphedemaRobert E Ferrell, Catherine J Baty, Mark A Kimak, et al.
Scientific Reports|August 10, 2024
Neuromuscular dysfunction and pathogenesis in triosephosphate isomerase deficiencyTracey D Myers, Yizhi Li, Stefanie Taiclet, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Physiology|July 13, 2014
Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonistTyler B Tarr, David Lacomis, Stephen W Reddel, et al.
Frontiers in Cellular Neuroscience|July 21, 2025
Chronic benzodiazepine treatment triggers gephyrin scaffold destabilization and GABA<sub>A</sub>R subsynaptic reorganizationCaitlyn A Chapman, Nadya Povysheva, Tyler B Tarr, et al.
Human Molecular Genetics|February 9, 2023
Potentiation of neuromuscular transmission by a small molecule calcium channel gating modifier improves motor function in a severe spinal muscular atrophy mouse modelKristine S Ojala, Cassandra J Kaufhold, Mykenzie R Davey, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 21, 2013
Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndromeTyler B Tarr, Waqas Malick, Mary Liang, et al.
Annals of the New York Academy of Sciences|November 11, 2017
Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leadsStephen D Meriney, Tyler B Tarr, Kristine S Ojala, et al.
Journal of Neurophysiology|April 19, 2023
Simulations of active zone structure and function at mammalian NMJs predict that loss of calcium channels alone is not sufficient to replicate LEMS effectsScott P Ginebaugh, Yomna Badawi, Rozita Laghaei, et al.
Journal of Cell Science|March 11, 2010
Sustained synaptic-vesicle recycling by bulk endocytosis contributes to the maintenance of high-rate neurotransmitter release stimulated by glycerotoxinFrederic A Meunier, Tam H Nguyen, Cesare Colasante, et al.
Journal of Neurophysiology|January 24, 2018
Transmitter release site organization can predict synaptic function at the neuromuscular junctionRozita Laghaei, Jun Ma, Tyler B Tarr, et al.
American Journal of Human Genetics|June 12, 2010
GJC2 missense mutations cause human lymphedemaRobert E Ferrell, Catherine J Baty, Mark A Kimak, et al.
Scientific Reports|August 10, 2024
Neuromuscular dysfunction and pathogenesis in triosephosphate isomerase deficiencyTracey D Myers, Yizhi Li, Stefanie Taiclet, et al.
Pageof 5